EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PLXDC1 + Tumor‐Associated Pancreatic Stellate Cells Promote Desmoplastic and Immunosuppressive Niche in Pancreatic Ductal Adenocarcinoma

Yanhua Du, Yizhou Zhao, Judong Li, Jiaxin Wang, Shenglan You, Yao Zhang, Li Zhang, Jihong Yang, Hamid Alinejad-Rokny, Shujie Cheng, Chenghao Shao, Duowu Zou und 1 weitere

Advanced Science · 2025-05 · 12 (18)

DOI: 10.1002/advs.202415756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.03.2025. Verfasst von Yanhua Du und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong Universit…. Hauptthemen laut MEDLINE: Pancreatic Stellate Cells, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, National Natural Science Foundation of China, Natural Science Foundation of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic stellate cells (PSCs) contribute to pancreatic ductal adenocarcinoma (PDAC) progression and therapeutic resistance, yet their detailed functions remain unclear. This study combined RNA sequencing and assay for transposase‐accessible chromatin using sequencing (ATAC‐seq) on sorted PSCs from adjacent normal and PDAC tissues to investigate their transcriptional and epigenetic activation. PSCs heterogeneity and functions are characterized through bulk, single‐cell, and spatial transcriptomes, as well as in situ sequencing. The clinical relevance of PSCs in immunotherapy is assessed using an in‐house immune‐checkpoint blockade (ICB) treatment cohort. Findings showed that stress and hypoxia signaling activated PSCs in PDAC. Three common PSCs (CPSCs) and four tumor‐associated PSCs (TPSCs) are identified, each with distinct functions. CPSCs differentiated into CCL19 + TPSCs in immune‐enriched regions, MYH11 + TPSCs in the stromal region, and PLXDC1 + TPSCs, which exhibited cancer‐associated myofibroblasts (myCAFs) phenotype linked to poor prognosis. Notably, PLXDC1 + TPSCs, located near aggressive LRRC15 + myCAFs and SPP1 + macrophages, formed a desmoplastic and immunosuppressive niche around the tumor boundary, promoting CD8 T cell exhaustion. Single‐cell transcriptomics of PDAC patients treated with ICB revealed that PLXDC1 + TPSCs correlated with poor immunotherapy efficacy. Overall, this study provides key insights into PSCs in PDAC and potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic Stellate CellsCarcinoma, Pancreatic DuctalPancreatic NeoplasmsHumansTumor Microenvironment

Stichwörter der Autor:innen

activation, heterogeneityimmunotherapy resistancepancreatic stellate cells (PSCs); PLXDC1+ tumor‐associated PSCssingle‐cell and spatial transcriptomes

Autor:innen und Institutionen

  • Center for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200001, China.
  • Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, State Key Laboratory of Systems Medicine for Cancer, Shanghai Jiao Tong University School of Medicine, Shanghai, 20025, China.
  • Department of Pancreatic-biliary Surgery, Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.
  • Department of Hepatobiliary Surgery, Hebei Key Laboratory of General Surgery for Digital Medicine, Affiliated Hospital of Hebei University, Baoding, 071000, China.
  • UNSW BioMedical Machine Learning Lab (BML), School of Biomedical Engineering, UNSW Sydney, Sydney, NSW, 2052, Australia.

ORCID-Profile: Youqiong Ye

Förderung

  • National Key Research and Development Program
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • Shanghai Jiao Tong University 2030 Initiative
  • Research Funds of Centre for Leading Medicine and Advanced Technologies of IHM
  • National Key Research and Development Program of China
  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Du, Y., Zhao, Y., Li, J., Wang, J., You, S., Zhang, Y., Zhang, L., Yang, J., Alinejad-Rokny, H., Cheng, S., Shao, C., Zou, D., & Ye, Y. (2025). PLXDC1 + Tumor‐Associated Pancreatic Stellate Cells Promote Desmoplastic and Immunosuppressive Niche in Pancreatic Ductal Adenocarcinoma. Advanced Science, 12(18). https://doi.org/10.1002/advs.202415756

Vancouver

Du Y, Zhao Y, Li J, Wang J, You S, Zhang Y, et al. PLXDC1 + Tumor‐Associated Pancreatic Stellate Cells Promote Desmoplastic and Immunosuppressive Niche in Pancreatic Ductal Adenocarcinoma. Advanced Science. 2025;12(18). doi:10.1002/advs.202415756

BibTeX
@article{Du2025,
  author = {Du, Yanhua and Zhao, Yizhou and Li, Judong and Wang, Jiaxin and You, Shenglan and Zhang, Yao and Zhang, Li and Yang, Jihong and Alinejad-Rokny, Hamid and Cheng, Shujie and Shao, Chenghao and Zou, Duowu and Ye, Youqiong},
  title = {PLXDC1 + Tumor‐Associated Pancreatic Stellate Cells Promote Desmoplastic and Immunosuppressive Niche in Pancreatic Ductal Adenocarcinoma},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {18},
  doi = {10.1002/advs.202415756}
}
Kostenlos starten →